Crewe Advisors LLC Eli Lilly & CO Transaction History

Crewe Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $57,264 - $71,814	-79 Reduced 5.16%	1,452 $1.31 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $906,658 - $1.21 Million	1,531 New	1,531 $1.19 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $60,678 - $81,133	-173 Reduced 18.33%	771 $361,000
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $47,837 - $56,182	154 Added 19.49%	944 $324,000
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $77,815 - $90,670	-242 Reduced 23.45%	790 $289,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $28,758 - $32,773	97 Added 10.37%	1,032 $334,000
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $96,161 - $112,908	345 Added 58.47%	935 $303,000
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $9,027 - $11,677	50 Added 9.26%	590 $135,000
Q4 2020 Jan 27, 2021	SELL	$130.46 - $172.63 $4,174 - $5,524	-32 Reduced 5.59%	540 $91,000
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $19,301 - $22,325	132 Added 30.0%	572 $85,000
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $23,467 - $26,932	-310 Reduced 41.33%	440 $38,000
Q1 2018 May 07, 2018	BUY	$74.21 - $87.6 $13,060 - $15,417	176 Added 30.66%	750 $58,000
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $47,033 - $50,448	574	574 $48,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.